[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:liver-embryonal-sarcoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Liver Embryonal Sarcoma",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06198296","Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells",[11],"Phase 1","RECRUITING","2026-08-26T02:16:39.977107Z","2026-05-05T02:43:29.711287Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07148050","Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells",[11],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.698343Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT03959800","Molecular Basis of Pediatric Liver Cancer",[],"2026-08-26T02:19:11.399072Z","2026-05-13T02:55:06.181246Z",[],[]]